uniQure to Present at the Jefferies 2015 Healthcare Conference
May 27, 2015 11:12 ET
|
uniQure
AMSTERDAM, The Netherlands, May 27, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the...
uniQure Announces Closing of Strategic Collaboration with Bristol-Myers Squibb to Develop Gene Therapies for Cardiovascular Disease
May 26, 2015 09:30 ET
|
uniQure
AMSTERDAM, the Netherlands, May 26, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the closing of its strategic collaboration with Bristol-Myers...
uniQure Announces Closing of Follow-on Public Offering
April 15, 2015 13:00 ET
|
uniQure
AMSTERDAM, The Netherlands, April 15, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the closing of its previously announced follow-on public...
uniQure Announces Pricing of Follow-on Public Offering
April 09, 2015 20:00 ET
|
uniQure
AMSTERDAM, Netherlands, April 9, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the pricing of its follow-on public offering of 3,000,000 ordinary...
uniQure Announces Launch of Follow-on Public Offering
April 07, 2015 16:29 ET
|
uniQure
Amsterdam, The Netherlands, April 7, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that it has commenced a follow-on public offering of...
uniQure Announces Webcast to Discuss Bristol-Myers Squibb Collaboration
April 06, 2015 08:19 ET
|
uniQure
AMSTERDAM, The Netherlands, April 6, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that at 8:30 EDT/14:30 CET today April 6, 2015, the Company...
uniQure Announces Results for Fourth Quarter and Financial Year 2014
April 06, 2015 08:18 ET
|
uniQure
AMSTERDAM, The Netherlands, April 6, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced unaudited results for the fourth quarter and year ending...
uniQure to Present at the at the Cowen and Company 35th Annual Health Care Conference
February 23, 2015 09:38 ET
|
uniQure
Amsterdam, The Netherlands, Feb. 23, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the...
uniQure to Present at the at the Leerink Partners Global Healthcare Conference
February 06, 2015 05:48 ET
|
uniQure
AMSTERDAM, the Netherlands, Feb. 6, 2015 (GLOBE NEWSWIRE) -- uniQure to Present at the at the Leerink Partners Global Healthcare Conference
Amsterdam, the Netherlands, February 6, 2015 - uniQure N.V....
uniQure Appoints Matthew Kapusta as Chief Financial Officer
January 09, 2015 05:08 ET
|
uniQure
AMSTERDAM, the Netherlands, Jan. 9, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that Matthew Kapusta has joined uniQure's management team as...